Arcascope, Inc. – Trademark Portfolio
Entity Type: 03
Arcascope, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include ARCASYNC, ARCASCOPE, ARCASHIFT, and CHRONORCT. The owner is based in Arlington, VA.
4075 Wilson Blvd, Floor 8
Arlington, VA 22203
Showing of trademarks Trademarks
Trademark Classifications
Arcascope, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Arcascope, Inc. have?
Arcascope, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned.
What trademark classes does Arcascope, Inc. file in?
Arcascope, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Arcascope, Inc.'s most well-known trademarks?
Arcascope, Inc.'s registered trademark portfolio includes well-known marks such as ARCASYNC, ARCASCOPE, ARCASHIFT, and CHRONORCT. These are among 4 currently registered trademarks in the portfolio.
What is Arcascope, Inc.'s trademark registration success rate?
Arcascope, Inc. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.